Start Date
February 28, 2015
Primary Completion Date
July 31, 2017
Study Completion Date
November 30, 2017
Eculizumab
"Eculizumab induction: 900 mg IV every 7 days for 4 doses, a fifth 1200 mg dose 7 days later Eculizumab maintenance: 15 1200 mg doses every 14 days.~(each patient will receive a total of 20 eculizumab doses during the whole treatment period from 3 month to 12 month post-transplant)."
Collaborators (1)
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Alexion Pharmaceuticals, Inc.
INDUSTRY
Assistance Publique - Hôpitaux de Paris
OTHER